Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prospects for a respiratory syncytial virus vaccine.

× No keyword cloud information.

28 in total

1. Respiratory syncytial virus immunoprophylaxis: impact on epidemiology.

Authors: N N Dougherty; H C Meissner
Journal: Paediatr Drugs Date: 2000 Mar-Apr Impact factor: 3.022

2. Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV disease.

Authors: H C Meissner; J R Groothuis; W J Rodriguez; R C Welliver; G Hogg; P H Gray; R Loh; E A Simoes; P Sly; A K Miller; A I Nichols; D K Jorkasky; D E Everitt; K A Thompson
Journal: Antimicrob Agents Chemother Date: 1999-05 Impact factor: 5.191

3. Tissue distribution of cholinesterases and anticholinesterases in native and transgenic tomato plants.

Authors: Samuel P Fletcher; Brian C Geyer; Amy Smith; Tama Evron; Lokesh Joshi; Hermona Soreq; Tsafrir S Mor
Journal: Plant Mol Biol Date: 2004-05 Impact factor: 4.076

4. Lower airway disease caused by respiratory syncytial virus.

Authors: R Aggarwal
Journal: Indian J Pediatr Date: 1998 May-Jun Impact factor: 1.967

5. Characterization of a novel respiratory syncytial virus-specific human cytotoxic T-lymphocyte epitope.

Authors: P J Goulder; F Lechner; P Klenerman; K McIntosh; B D Walker
Journal: J Virol Date: 2000-08 Impact factor: 5.103

Review 6. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors: D R Lucey; M Clerici; G M Shearer
Journal: Clin Microbiol Rev Date: 1996-10 Impact factor: 26.132

7. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development.

Authors: P L Collins; M G Hill; E Camargo; H Grosfeld; R M Chanock; B R Murphy
Journal: Proc Natl Acad Sci U S A Date: 1995-12-05 Impact factor: 11.205

8. Strain-specific reverse transcriptase PCR assay: means to distinguish candidate vaccine from wild-type strains of respiratory syncytial virus.

Authors: H Zheng; T C Peret; V B Randolph; J C Crowley; L J Anderson
Journal: J Clin Microbiol Date: 1996-02 Impact factor: 5.948

9. Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein.

Authors: H Plotnicky-Gilquin; L Goetsch; T Huss; T Champion; A Beck; J F Haeuw; T N Nguyen; J Y Bonnefoy; N Corvaïa; U F Power
Journal: J Virol Date: 1999-07 Impact factor: 5.103

10. Persistent activation of RelA by respiratory syncytial virus involves protein kinase C, underphosphorylated IkappaBbeta, and sequestration of protein phosphatase 2A by the viral phosphoprotein.

Authors: V Bitko; S Barik
Journal: J Virol Date: 1998-07 Impact factor: 5.103